Cerebrospinal fluid markers of prion diseases

被引:0
|
作者
Golanska, Ewa [1 ]
Gresner, Sylwia [1 ]
Sieruta, Monika [1 ]
Liberski, Powel [1 ]
机构
[1] Uniwersytet Medyczny Lodzi, Zaklad Patol Mol & Neuropatol, PL-92216 Lodz, Poland
关键词
Creutzfeldt-Jakob disease; 14-3-3; protein; biochemical markers; cerebrospinal fluid; diagnostic tests;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are no non-invasive tests allowing for definite premortem diagnosis of Creutzfeldt-Jakob disease (CJD). The paper presents the Current knowledge about laboratory tests supporting CJD diagnosis. 14-3-3 protein in the cerebrospinal fluid Is the only biochemical marker included in the diagnostic criteria for CJD approved by WHO. However, the test for 14-3-3 protein is useful Only when considered in an appropriate clinical context, together with other diagnostic criteria. In the paper we also present current research In the use of other proteins detected in the cerebrospinal fluid (tau, S100b, neuron-specific enolase, transthyretin, and beta-amyloid(1-42) as potential diagnostic markers. We discuss advantages and drawbacks of these markers.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 50 条
  • [31] Clinical Correlates of Cerebrospinal Fluid 14-3-3 Protein in Non-Prion Rapid Progressive Dementia
    Kong, Yu
    Chen, Zhongyun
    Shi, Qi
    Zuo, Ya
    Zhang, Jing
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (01) : 263 - 272
  • [32] Prion Diseases
    Venneti, Sriram
    CLINICS IN LABORATORY MEDICINE, 2010, 30 (01) : 293 - +
  • [33] CEREBROSPINAL-FLUID MARKERS IN NEUROLOGICAL DISORDERS
    MASSARO, AR
    SCIVOLETTO, G
    TONALI, P
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 11 (06): : 537 - 547
  • [34] Cerebrospinal fluid markers in multiple sclerosis: an overview
    Massaro, AR
    Tonali, P
    MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (01) : 1 - 4
  • [35] β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
    Bing Xu
    Kang Xiao
    Xiaoxi Jia
    Rundong Cao
    Donglin Liang
    Ruhan A
    Weiwei Zhang
    Chunjie Li
    Liping Gao
    Cao Chen
    Qi Shi
    Xiaoping Dong
    Alzheimer's Research & Therapy, 17 (1)
  • [36] Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases
    Zdenek Rohan
    Magdalena Smetakova
    Jaromir Kukal
    Robert Rusina
    Radoslav Matej
    BMC Neurology, 15
  • [37] Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
    Mane Martinez, M. Alba
    Olsson, Bob
    Bau, Laura
    Matas, Elisabet
    Cobo Calvo, Alvaro
    Andreasson, Ulf
    Blennow, Kaj
    Romero-Pinel, Lucia
    Martinez-Yelamos, Sergio
    Zetterberg, Henrik
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (05) : 550 - 561
  • [38] Amplification techniques and diagnosis of prion diseases
    Brandel, J-P
    Culeux, A.
    Grznaroua, K.
    Levavasseur, E.
    Lamy, P.
    Privat, N.
    Welaratne, A.
    Denouel, A.
    Laplanche, J-L
    Haik, S.
    REVUE NEUROLOGIQUE, 2019, 175 (7-8) : 458 - 463
  • [39] Ultrasensitive detection of PrPSc in the cerebrospinal fluid and blood of macaques infected with bovine spongiform encephalopathy prion
    Murayama, Yuichi
    Masujin, Kentaro
    Imamura, Morikazu
    Ono, Fumiko
    Shibata, Hiroaki
    Tobiume, Minoru
    Yamamura, Tomoaki
    Shimozaki, Noriko
    Terao, Keiji
    Yamakawa, Yoshio
    Sata, Tetsutaro
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 2576 - 2588
  • [40] Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease
    Wong, BS
    Green, AJE
    Li, RL
    Xie, ZL
    Pan, T
    Liu, T
    Chen, SG
    Gambetti, P
    Sy, MS
    JOURNAL OF PATHOLOGY, 2001, 194 (01) : 9 - 14